Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jul 15 2025

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jul-15-2025-2

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated July 15, 2025, titled "Zydus receives final approval from USFDA for Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases